Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
about
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cellsPancreatic cancer: pathogenesis, prevention and treatmentEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.miR-146a suppresses invasion of pancreatic cancer cellsTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayCombined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancerPotential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization AssayTargeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasisData to establish the optimal standard regimen and predicting the response to docetaxel therapyBioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancerUp-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells.Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells.Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.Current knowledge on pancreatic cancer.Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity.A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.Safety of purified isoflavones in men with clinically localized prostate cancerUnderstanding and targeting osteoclastic activity in prostate cancer bone metastases.Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?Multi-targeted therapy of cancer by genisteinRANKL/RANK/OPG: key therapeutic target in bone oncology.Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cellsPerspectives on the role of isoflavones in prostate cancer.Perspectives for cancer prevention with natural compoundsDown-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.Role of phytoestrogens in cancer therapy.Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerMolecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Risks and benefits of dietary isoflavones for cancer.Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities.Diagnostic and prognostic role of matrix metalloproteases in cancer.
P2860
Q24651034-A0DE98D0-65FF-4B47-BB0D-E374B886E432Q24670990-7A75746D-03FA-4C53-A976-4C09AC73E636Q26827810-4DA71E0E-7730-4D83-9212-0B62E168CB5FQ28272101-ADF58FB7-EE5A-4EC0-8010-4800F57AC158Q28382812-5E21074C-33D0-47DD-BA47-8A470F881084Q28534382-9370B592-E585-4774-8B0E-7DE89458A2EBQ28546630-0DCA1B85-126E-4F29-A17E-3AE16E6F8E8EQ28731449-C8206882-8B4C-492C-B05F-86EFDD687482Q31027264-27965672-C611-4709-9D9C-86BA125A7D1BQ33567159-1C3375D4-5E29-4F6A-AC11-22D36784AC34Q33787995-413E6D88-50F2-47B4-A88D-0461E26F060EQ34199678-1C9D7400-AA74-46F0-8339-64B1D14F605DQ34228887-67C01ED2-AC9F-4164-ABB6-2CA23A954C48Q34976272-DC12A854-B2EA-42FE-A861-5D8E36B3591BQ35287094-3A6C5B1E-3FF1-4193-A45C-C99AFDEE7256Q35688200-3F3FCF39-C4E7-49DC-A0AC-20A401B5622BQ35746535-94A46AD3-5748-4F9F-B888-97669EB52C2CQ35823852-17D6AD7B-9083-4006-92A1-0DCD2221134EQ35844645-FE1E7786-588C-4D23-97AE-980E4F2F4919Q35971808-AF41D7D0-B3BE-462B-B95F-DD9698F3EB02Q36052535-3F6725DF-4D45-45D0-AD2C-D04AC0208C2BQ36082397-BE7720C1-485E-4735-A04A-E90B322B40D4Q36732271-98960C49-6C49-4CAB-B394-B57197882727Q36738875-B7E0EEE0-4BDF-4D74-9096-CBAAF3441164Q36741928-C9452262-7E21-44C2-ACEC-DEE7449D142EQ36759374-0D635BA5-2331-4C0C-A50F-91F3B317680CQ36945706-1E5DDEEA-DBA6-461B-9EC3-26DAF96657B1Q36955543-5EAB4D5E-E33A-4129-BF38-F6E11038DC8FQ37140665-9F8DE561-B5C9-408B-9B58-4586370CB87CQ37154190-20850318-E105-4B7E-9685-6D7F19523832Q37207772-BD8598FB-B7D7-48C4-8FC9-3924E143688CQ37212228-41E22FFB-E415-4EDB-AEB3-B5D2481FA711Q37220370-6E917D8D-DCA7-4D42-BA68-A0DB787FE1A3Q37238391-276C6AEA-9BA9-40FE-B682-F1F4D2FE16F6Q37376217-A0B39796-245B-4BE5-8286-B73111D85016Q37576761-C309FC44-D691-43E7-B757-C84181ADFC39Q37654590-2EC216DA-B788-436F-AE38-3FEBF3284E22Q37857841-DDB0A6D2-DFDC-43C0-B175-BFCCF0305C4FQ37982235-FCCC1D6B-2221-4B9B-98F4-0FD60FE59ABDQ38089795-01481CA6-BF5F-4842-82E1-305F12FF5597
P2860
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antitumor and antimetastatic a ...... signaling in prostate cancer.
@en
type
label
Antitumor and antimetastatic a ...... signaling in prostate cancer.
@en
altLabel
Antitumor and Antimetastatic A ...... 9 Signaling in Prostate Cancer
@en
prefLabel
Antitumor and antimetastatic a ...... signaling in prostate cancer.
@en
P2093
P1433
P1476
Antitumor and antimetastatic a ...... signaling in prostate cancer.
@en
P2093
Judith Abrams
Maha Hussain
Michael L Cher
Omer Kucuk
P304
P356
10.1158/0008-5472.CAN-05-3752
P407
P577
2006-05-01T00:00:00Z